275 related articles for article (PubMed ID: 14678279)
1. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.
Selga D; Segelmark M; Wieslander J; Gunnarsson L; Hellmark T
Clin Exp Immunol; 2004 Jan; 135(1):164-72. PubMed ID: 14678279
[TBL] [Abstract][Full Text] [Related]
2. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases.
Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Specks U
J Immunol Methods; 2005 Dec; 307(1-2):62-72. PubMed ID: 16242707
[TBL] [Abstract][Full Text] [Related]
3. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
[TBL] [Abstract][Full Text] [Related]
4. Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice.
Kim YC; Choi YS; Alam J; Kim YJ; Baek KJ; Koh J; Song YW; Chung DH; Choi Y
Immunol Res; 2016 Apr; 64(2):438-44. PubMed ID: 26318749
[TBL] [Abstract][Full Text] [Related]
5. Discrimination and variable impact of ANCA binding to different surface epitopes on proteinase 3, the Wegener's autoantigen.
Silva F; Hummel AM; Jenne DE; Specks U
J Autoimmun; 2010 Dec; 35(4):299-308. PubMed ID: 20810247
[TBL] [Abstract][Full Text] [Related]
6. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
7. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
[TBL] [Abstract][Full Text] [Related]
8. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
9. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody.
Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J
Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537
[TBL] [Abstract][Full Text] [Related]
11. [New aspects of antineutrophil cytoplasmic antibody (ANCA) diagnosis in vasculitis].
Csernok E; Reichel P; Gross WL
Z Rheumatol; 2002 Aug; 61(4):367-77. PubMed ID: 12426842
[TBL] [Abstract][Full Text] [Related]
12. Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies.
Chang L; Binos S; Savige J
Clin Exp Immunol; 1995 Oct; 102(1):112-9. PubMed ID: 7554377
[TBL] [Abstract][Full Text] [Related]
13. Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.
Fienberg R; Mark EJ; Goodman M; McCluskey RT; Niles JL
Hum Pathol; 1993 Feb; 24(2):160-8. PubMed ID: 8381764
[TBL] [Abstract][Full Text] [Related]
14. Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.
Van Der Geld YM; Limburg PC; Kallenberg CG
Clin Exp Immunol; 1999 Dec; 118(3):487-96. PubMed ID: 10594572
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
[TBL] [Abstract][Full Text] [Related]
17. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection.
Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S
Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276
[TBL] [Abstract][Full Text] [Related]
18. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
Front Immunol; 2020; 11():573040. PubMed ID: 33101296
[TBL] [Abstract][Full Text] [Related]
19. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
van der Geld YM; Stegeman CA; Kallenberg CG
Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
[TBL] [Abstract][Full Text] [Related]
20. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
